Table A1.

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer Update Committee Membership

Name (and designation)	Affiliation/Institution	Role/Area of Expertise
Harold J. Burstein, MD, PhD	Dana-Farber Cancer Institute, Boston, MA	Medical oncology
Jennifer J. Griggs, MD MPH	University of Michigan, Ann Arbor, MI	Medical oncology
Holly Anderson	Breast Cancer Coalition of Rochester, Rochester, NY	Patient representative
Thomas A. Buchholz, MD	MD Anderson Cancer Center, Houston, TX	Radiation oncology
Nancy E. Davidson, MD	University of Pittsburgh Cancer Institute and UPMC CancerCenter, Pittsburgh, PA	Medical oncology
Karen E. Gelmon, MD	British Columbia Cancer Agency, Vancouver, BC	Medical oncology
Sharon H. Giordano, MD	MD Anderson Cancer Center, Houston, TX	Medical oncology
Clifford A. Hudis, MD	Memorial Sloan Kettering Cancer Center, New York, NY	Medical oncology
Diana Rowden, MA	Dallas, TX	Patient advocate
Alexander J. Solky, MD	Interlakes Onc and Hem PC, Rochester, NY	Community oncology
Vered Stearns, MD	Johns Hopkins School of Medicine, Baltimore, MD	Medical oncology
Eric P. Winer, MD	Dana-Farber Cancer Institute, Boston, MA	Medical oncology

NOTE. ASCO Staff: Sarah Temin, MSPH.